Samsara BioCapital’s BioNTech BNTX Stock Holding History

Samsara BioCapital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,031	Closed	-$688K	–	59
2022 Q1	$688K	Hold	4,031	–	–	0.17%	50
2021 Q4	$1.04M	Sell	4,031 -1,727	-30%	-$473K	0.2%	44
2021 Q3	$1.57M	Hold	5,758	–	–	0.25%	43
2021 Q2	$1.29M	Sell	5,758 -5,037	-47%	-$950K	0.16%	47
2021 Q1	$1.18M	Hold	10,795	–	–	0.22%	41
2020 Q4	$880	Sell	10,795 -1,905	-15%	-$187K	0.09%	39
2020 Q3	$879K	Buy	+12,700	New	+$911K	0.25%	34

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Samsara BioCapital's BNTX Position: Q2 2022 in Review

Samsara BioCapital sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 4,031 shares — an estimated $688K sold.

Samsara BioCapital first reported a position in BNTX in Q3 2020 and held it in 7 quarters. The position peaked at $1.57M in Q3 2021. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

Samsara BioCapital reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
Samsara BioCapital sold 4,031 BioNTech shares in Q2 2022, an estimated $688K.
Samsara BioCapital first reported a position in BioNTech in Q3 2020 and held it in 7 quarters.
Samsara BioCapital's BioNTech position peaked at $1.57M in Q3 2021.
293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Samsara BioCapital's 13F filing for Q2 2022, filed 15 Aug 2022.